Rivus Pharmaceuticals announces the appointment of Jorge Bartolome as Chief Executive Officer and member of the Board. He is a pharmaceutical veteran with extensive late-stage development and commercial experience and joins to lead Rivus as it advances its pipeline of oral medicines that leverage energy expenditure for the treatment of MASH, obesity, and associated cardiometabolic diseases.
Rivus Pharmaceuticals announces the appointment of Jorge Bartolome as Chief Executive Officer and member of the Board. He is a pharmaceutical veteran with extensive late-stage development and commercial experience and joins to lead Rivus as it advances its pipeline of oral medicines that leverage energy expenditure for the treatment of MASH, obesity, and associated cardiometabolic diseases.